Medical Research and Surveillance Services
ID: HT942525R0004Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH (AJ11)
Timeline
    Description

    The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking proposals for a contract to provide medical research and surveillance services in Laos, focusing on infectious diseases. The primary objective is to conduct comprehensive research on malaria prevalence, antimalarial drug resistance, and other emerging infections, while supporting the Armed Forces Research Institute of Medical Sciences (AFRIMS) in collaboration with local health authorities. This initiative is crucial for enhancing health security and epidemiological research capabilities in the region, with the contract spanning from December 2024 to September 2029. Interested contractors should contact John Fitzsimmons at john.l.fitzsimmons8.civ@health.mil or Jennifer Jackson at jennifer.c.jackson18.civ@health.mil for further details and to ensure compliance with submission deadlines outlined in the solicitation.

    Point(s) of Contact
    Files
    Title
    Posted
    The Performance Work Statement (PWS) outlines a non-personal services contract for the Armed Forces Research Institute of Medical Sciences (AFRIMS) to conduct infectious disease surveillance and research in Laos. The objective is to study malaria prevalence and drug resistance, alongside antimicrobial-resistance surveillance, focusing on both military personnel and the local population. AFRIMS, part of the Walter Reed Army Institute of Research (WRAIR), aims to enhance its ongoing projects and expand research in collaboration with the Lao Ministries of National Defense and Public Health. The contract spans multiple periods from December 2024 through September 2029 and includes provisions for quality control, personnel qualifications, and adherence to local regulations. Tasks involve subject recruitment, sample collection and testing, data management, and coordination of research projects. The contractor is responsible for complying with human subjects protection protocols and maintaining proper documentation. The contract emphasizes safety, environmental compliance, and procedures for reporting deviations and issues. Overall, it reflects the U.S. government's commitment to bolster health security through comprehensive epidemiological research in Laos.
    The Quality Assurance Surveillance Plan (QASP) for the Infectious Disease Surveillance (IDS) contract in Laos outlines a systematic approach for evaluating contractor performance. The main focus is on monitoring research for emerging infectious diseases, specifically malaria prevalence and antimalarial drug resistance among the Lao People’s Armed Forces. Key components include identifying eligible study subjects, shipping samples to AFRIMS, and conducting laboratory procedures to meet public health standards. The document delineates roles and responsibilities of government personnel involved in monitoring the contract, including the Contracting Officer, Contract Specialist, and Contracting Officer’s Representative (COR). It emphasizes objective, fair evaluation while acknowledging that the contractor is responsible for management and quality control. Performance metrics are provided in a summary matrix, detailing acceptable quality levels (AQLs) and methods for assessing performance. Additionally, there are provisions for documenting performance inconsistencies and corrective actions via a Contract Discrepancy Report. Overall, the QASP serves to facilitate effective contract management and ensure compliance with health and research protocols, illustrating the government’s commitment to transparency and accountability in public health initiatives.
    The government file outlines the pricing structure for the "IDS in Laos" project, detailing multiple Contract Line Item Numbers (CLINs) and their associated costs under Firm Fixed Price (FFP) structures. It specifies various job categories across different periods including a base period and multiple option periods. Each CLIN documents the type, estimated costs, and proposed levels of effort along with applicable labor rates. The pricing sheet culminates in a total estimated price for all contract periods and subcategories. The document emphasizes transparency in the pricing strategy for federal grants and RFPs, allowing agencies to scrutinize the contractor's proposed labor rates, levels of effort, and additional costs if necessary. This detailed approach is critical for maintaining budgetary compliance and facilitating better government oversight. It highlights the essential components of contract proposals, aligning with the objective of ensuring responsible fiscal management in government-funded projects.
    The document outlines a Request for Proposal (RFP) from the U.S. Army Medical Research Acquisition Activity for research support services related to infectious disease surveillance and research projects in Laos. Issued on October 7, 2024, the RFP specifies requirements for delivering various research support services, including site support, surge projects, and other direct costs associated with travel and materials. The contract includes options for extending support over subsequent years, with specific pricing structures for fixed-price contracts. The solicitation details the submission process, including deadlines for inquiries and proposals. Offerors must submit a comprehensive proposal consisting of a business proposal, technical approach, and past performance information. Formatting guidelines for proposal submissions are provided, emphasizing clarity and organization. The evaluation will consider factors such as the completeness of submissions and relevance to the outlined performance work statement. The overarching goal of the RFP is to obtain reliable research support to enhance U.S. military capabilities in addressing infectious diseases, demonstrating the government's commitment to improving health surveillance and research efforts in international contexts.
    Lifecycle
    Title
    Type
    Solicitation
    Similar Opportunities
    Commissioning Agent Request for Information (RFI) for USAMRIID, Federal Research Laboratory
    Active
    Dept Of Defense
    The Department of Defense, through the Army Medical Research Acquisition Activity (USAMRAA), is seeking responses to a Request for Information (RFI) regarding compliance support for select agent and biological safety regulations at the new US Army Medical Research Institute of Infectious Diseases (USAMRIID) Building 8100 in Frederick, Maryland. The RFI aims to identify contractors with the expertise to conduct a gap analysis for CDC registration processes and provide regulatory compliance support for high-containment laboratory operations, particularly focusing on systems such as effluent decontamination, building automation, and electronic security. This opportunity is critical for ensuring the facility meets stringent biosafety standards as it transitions to operational status, with a contract duration of one year and the possibility of four additional option years. Interested parties must submit their capabilities statements by 30 October 2024, and inquiries can be directed to Tonya Kreps at tonya.r.kreps.civ@health.mil.
    PANMRA-24-P-0000_005879 AI for Infectious Disease Threats
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to award a sole-source contract for the development of Artificial Intelligence (AI) and Machine Learning (ML) solutions aimed at screening drug compounds against infectious disease threats. The primary objective is to establish an Indefinite Delivery Indefinite Quantity (IDIQ) contract that will enable the contractor to utilize in silico screening methods to evaluate millions of approved and novel compounds against various targets identified by the government, focusing on the identification of drug-like ligands and assessing potential toxicity and metabolic liabilities. This initiative is crucial for advancing therapeutic options against infectious diseases, leveraging cutting-edge technology to enhance drug discovery processes. Interested parties can direct inquiries to Linda Hinson at linda.t.hinson.civ@health.mil or Sharew Hailu at sharew.hailu.civ@health.mil for further information.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE DEPT OF THE ARMY is seeking extramural research and development ideas for medical research. The USAMRDC aims to provide solutions to medical problems for the American Service Member and the general public. This BAA solicits basic and applied research projects to advance medical science and technology. The selection process is highly competitive, and submissions are accepted throughout a 5-year period. Pre-proposals must be submitted through the electronic Biomedical Research Application Portal (eBRAP), and invited full proposals must be submitted through Grants.gov.
    RFP Material Testing for Chemical and Biological Threats
    Active
    Dept Of Defense
    The Department of Defense, specifically the Army's Combat Capabilities Development Command (DEVCOM), is soliciting proposals for a contract focused on material testing for chemical and biological protective materials. The primary objective is to engage a contractor capable of executing tests and evaluations on fabrics, garments, and protective ensembles against chemical warfare agents and toxic industrial chemicals, utilizing both standard and non-standard testing methods. This contract is critical for enhancing the protective capabilities of military personnel, ensuring compliance with stringent safety and quality standards. The contract is set to span five years, from October 2024 to September 2029, with a minimum order quantity of $95,000 and a maximum value of $3,035,000. Interested parties can reach out to Lyndon Jagroop at lyndon.s.jagroop.civ@army.mil or Linnea Jones at meri.l.jones.civ@army.mil for further information.
    Validation Lifecycle Management System (VLMS) with Maintenance, Technical Services and Support
    Active
    Dept Of Defense
    The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking proposals for a Validation Lifecycle Management System (VLMS) to enhance its validation lifecycle and ensure compliance with FDA regulations. The desired system is a Software as a Service (SaaS) solution that will streamline fragmented validation processes, improve regulatory audits, and include features such as role-based access control and a secure document repository. Interested vendors must submit a Capability Statement by October 18, 2024, detailing their qualifications, while adhering to confidentiality guidelines. For further inquiries, potential respondents can contact Lindsey Arthur at lindsey.b.arthur2.civ@health.mil or Justin Pickett at justin.h.pickett.civ@health.mil.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Active
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    BROAD AGENCY Announcement (BAA) FOR THE PROTECTION OF DEPLOYED MILITARY PERSONNEL FROM THREATS POSED BY DISEASE-CARRYING ARTHROPODS
    Active
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking NATIONAL DEFENSE R&D SERVICES for the protection of deployed military personnel from threats posed by disease-carrying arthropods. This BAA is intended to solicit pre-proposals for AFPMB for those parts of development not related to a specific system or hardware procurement. The purpose of this BAA is to identify the best available science. Specific areas of interest are described in the "Areas of Interest" section of this BAA. Awards are typically made under grants; however, other funding opportunities may be considered.
    2025 Southern Hemisphere Influenza Vaccine
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is soliciting proposals for the 2025 Southern Hemisphere Influenza Vaccine. This procurement aims to secure the necessary biological products to support immunization efforts for the upcoming influenza season. The vaccines are critical for public health and military readiness, ensuring that personnel are protected against seasonal influenza strains. Interested vendors can reach out to Rosbert Jones at rosbert.jones@dla.mil or 215-737-2380, or Yu Chen at yu.chen@dla.mil or 215-737-2103 for further details regarding the solicitation process.
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE Combat Readiness - Medical, Translational Research Award: The Department of Defense (DoD) is soliciting extramural research and development ideas through the Congressionally Directed Medical Research Programs (CDMRP) Fiscal Year 2024 Combat Readiness—Medical Research Program (CRRP) Translational Research Award (TRA). This Broad Agency Announcement (BAA) aims to fund research projects that are not related to the development of a specific system or hardware procurement. The research and development funded through this BAA is expected to benefit both military and civilian medical practice and knowledge. The BAA provides detailed information on the CRRP, evaluation criteria, and proposal/application preparation instructions. Extramural applicants, such as academic institutions, biotechnology companies, foundations, and research institutes, are eligible to apply. The submission process involves pre-proposal/pre-application submission through the electronic Biomedical Research Application Portal (eBRAP) and application submission through Grants.gov. The BAA can be downloaded from Grants.gov using the opportunity number HT9425S24CRRPTRA. For more information, refer to the provided link. The primary point of contact is the CDMRP Help Desk, reachable at help@eBRAP.org or 301-682-5507.
    ACC-APG Competitive Opportunities: Edgewood Contracting Division August 2024 update
    Active
    Dept Of Defense
    The Department of Defense, through the Army Contracting Command - Aberdeen Proving Ground (ACC-APG) Edgewood Contracting Division, is providing an update on upcoming contracting opportunities as of August 2024. This initiative aims to enhance communication with industry stakeholders regarding various Requests for Proposals (RFPs) focused on advanced military medical technologies, including diagnostic tools for distinguishing between bacterial and viral infections, biological sequencing, and chemical detection systems. These procurements are crucial for improving operational capabilities and supporting educational outreach, particularly in STEM fields for Minority Serving Institutions. Interested parties are encouraged to review the attached excel sheet for detailed opportunities and submit any questions via email to the designated point of contact within one week of the posting, noting that all information is subject to change and procurements may be canceled at any time.